Festoff B W, Smirnova I V, Ma J, Citron B A
Neurobiology Research Laboratory, Kansas City Veterans Affairs Medical Center, Missouri, USA.
Semin Thromb Hemost. 1996;22(3):267-71. doi: 10.1055/s-2007-999018.
The multifunctional serine protease, thrombin, the principal component of the blood coagulation cascade, is also active in nervous system growth and maintenance. In neural tissue culture, it prevents neurite outgrowth and modulates morphologic changes in both neurons and astrocytes. In recent studies, we found that it mediates polyneuronal synapse elimination, both in vivo and in vitro. Of relevance to neurologic disease, as well as to development, evidence also implicates thrombin in apoptosis of these cells. As with other serine proteases, thrombin is in "balance" with one or more endogenous protein inhibitors, members of the serpin superfamily of proteins. The most potent vertebrate inhibitor for thrombin is protease nexin I (PNI), which regulates thrombin's effect by forming post-translational, covalent complexes with the protease. We review some of the nervous system effects of the thrombin:PNI balance, and also present results of a recent study of this balance after peripheral nerve injury. We measured thrombin and prothrombin activity in extracts from adult mouse sciatic nerve using a specific chromogenic assay. We also performed reverse transcription polymerase chain reaction of RNA from nerve crush samples. We found a burst of activity at 3 days following injury distal to the crush site that was inhibited by thrombin specific inhibitors. It is possible that a significant fraction of the increased prothrombin in injured nerve was synthesized locally. Active PNI levels increased in these crush samples 6 to 9 days after the thrombin induction. These data suggest that nerve injury first induces the synthesis of prothrombin, which is subsequently converted to active thrombin. Nerve crush-induced thrombin is followed by the generation of functionally active PNI and may be directly responsible for its induction. These results suggest that the balance between serine proteases and their serpins is dysregulated during nerve injury and support a role for its reestablishment in nerve damage repair.
多功能丝氨酸蛋白酶凝血酶是血液凝固级联反应的主要成分,在神经系统的生长和维持中也具有活性。在神经组织培养中,它可阻止神经突生长,并调节神经元和星形胶质细胞的形态变化。在最近的研究中,我们发现它在体内和体外均介导多神经元突触消除。与神经疾病以及发育相关的是,有证据表明凝血酶也参与这些细胞的凋亡。与其他丝氨酸蛋白酶一样,凝血酶与一种或多种内源性蛋白质抑制剂(丝氨酸蛋白酶抑制剂超家族的成员)处于“平衡”状态。凝血酶最有效的脊椎动物抑制剂是蛋白酶连接蛋白I(PNI),它通过与蛋白酶形成翻译后共价复合物来调节凝血酶的作用。我们综述了凝血酶:PNI平衡对神经系统的一些影响,并展示了最近一项关于周围神经损伤后这种平衡的研究结果。我们使用特定的显色测定法测量成年小鼠坐骨神经提取物中的凝血酶和凝血酶原活性。我们还对神经挤压样本的RNA进行了逆转录聚合酶链反应。我们发现在挤压部位远端损伤后3天出现了一阵活性,这被凝血酶特异性抑制剂所抑制。损伤神经中凝血酶原增加的很大一部分可能是在局部合成的。在凝血酶诱导后6至9天,这些挤压样本中的活性PNI水平升高。这些数据表明,神经损伤首先诱导凝血酶原的合成,随后凝血酶原转化为活性凝血酶。神经挤压诱导的凝血酶之后是功能性活性PNI的产生,并且可能直接负责其诱导。这些结果表明,在神经损伤期间丝氨酸蛋白酶与其丝氨酸蛋白酶抑制剂之间的平衡失调,并支持其在神经损伤修复中重新建立平衡的作用。